Interleukin-6: a pathogenetic role in the postmenopausal osteoporosis?
Girasole
G
G
Istituto di Clinica Medica Generale e Terapia Medica, Università degli Studi di Parma.
Passeri
G
G
Pedrazzoni
M
M
Giuliani
N
N
Passeri
M
M
D000704:Analysis of Variance; D000818:Animals; D001853:Bone Marrow / Q000187:drug effects / Q000378:metabolism; D001854:Bone Marrow Cells; D002460:Cell Line; D002478:Cells, Cultured; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D006801:Humans; D007375:Interleukin-1 / Q000494:pharmacology; D015850:Interleukin-6 / Q000502:physiology*; D051379:Mice; D010010:Osteoclasts / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D015663:Osteoporosis, Postmenopausal / Q000209:etiology* / Q000378:metabolism; D010052:Ovariectomy; D011994:Recombinant Proteins / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
D007375:Interleukin-1; D015850:Interleukin-6; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D004958:Estradiol